According to research from the Kaiser Family Foundation, 12% of Americans say they have taken a GLP-1 drug for weight loss, diabetes treatment, or to reduce the risk of heart attack or stroke
The medication works by binding to GLP-1 receptors in pancreatic beta cells, enhancing glucose-dependent insulin secretion whilst suppressing inappropriate glucagon release
It means that our understanding of it must expand to include the bidirectional communication between gut, brain, immune system, and behavior
Why Trust Everyday Health Sarah Garone Author Julie Cunningham, MPH, RDN, LDN, CDCES Medical Reviewer Julie Cunningham is a registered dietitian-nutritionist and a certified diabetes care and education specialist
Utility of 'substance use disorder' as a heuristic for understanding overeating and obesity